Five Women File Yaz Side Effects Lawsuit in California
Five women banned together and filed a Yaz side effects lawsuit in the Superior Court of the State of California, San Francisco, on March 19, 2013. According to the complaint, all five plaintiffs suffered serious injuries after ingesting Yaz/Yasmin or Ocella. All are seeking Yaz lawsuit settlements or jury awards to cover past and future medical expenses, loss of earnings, impaired earning capacity, past and future mental and emotional distress.
Plaintiffs claim to have suffered from deep vein thrombosis
According to court documents, each of the five women resides in a different state, and alleges injuries stemming from the use of Yaz/Yasmin or Ocella.
- Roxanne Campbell, who resides in Florida, claims that after using the products, she suffered from venous thromboembolism and related health complications that require continuing treatment and medical monitoring.
- Gabriele Dean, a resident of Colorado, alleges to have suffered deep vein thrombosis (DVT) and related health complications requiring continued monitoring and treatment.
- Marla Hoffman of Ohio, claims to have suffered DVT and related problems.
- Suzanne Landry-Harmon, from Louisiana, says she has developed DVT and related problems.
- Dawn Meadows, a resident of Indiana, claims to have suffered DVT and other health issues.
All five women contend that manufacturer Bayer should have known that the use of their birth control products could cause deep vein thrombosis, and that it was unreasonably dangerous.
Yaz side effects lawsuit describes how drospirenone works in the body
The plaintiffs note in their complaint that Yaz, Yasmin and Ocella contain the fourth-generation progestin called “drospirenone,” which functions differently in the body than older progestins used in other contraceptives.
For instance, drospirenone causes an increase in potassium levels in the blood, which can lead to a condition called hyperkalemia. Untreated, hyperkalemia can cause heart rhythm disturbances, gallbladder complications, and kidney problems. Heart rhythm disturbances can also lead to a slower blood flow through the heart, which increases the risk of blood clots that can then lead to heart attack, pulmonary embolism, and stroke.
This Yaz side effects lawsuit also notes several scientific studies that have shown birth control pills containing drospirenone increase a patient’s risk of blood clots. As early as April 2002, the British Medical Journal reported that the Dutch College of General Practitioners recommended patients use older pills because of 40 cases of blood clots among women taking Yaz and Yasmin.
Patients seek Yaz lawsuit settlements or jury awards
Deep vein thrombosis is a condition cited frequently in Yaz claims against Bayer. It occurs when a blood clot forms in a deep vein in the body. If that blood clot then breaks off and travels to another critical organ, it can lead to pulmonary embolism, stroke, heart attack, and even death.
According to a 2011 study published in the Canadian Medical Association Journal, the use of drospirenone-containing oral contraceptives was associated with an increased risk of deep vein thrombosis and pulmonary embolism. That same year, the British Medical Journal also reported that birth control pills like Yaz, Yasmin, and Ocella put woman at two times the risk of developing blood clots compared to women who used older pills that did not contain drospirenone.
The plaintiffs in this Yaz side effects lawsuit bring counts of failure to warn, manufacturing defect, negligence, breach of warranties, deceit by concealment, negligent misrepresentation, and fraud.